Get the Stockscreener App
61.00
2.85%
-1.79
After Hours:
61.00
Prestige Consumer Healthcare Inc stock is traded at $61.00, with a volume of 365.14K.
It is down -2.85% in the last 24 hours and down -6.21% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$62.79
Open:
$62.76
24h Volume:
365.14K
Relative Volume:
0.69
Market Cap:
$3.00B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
14.84
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
-4.63%
1M Performance:
-6.21%
6M Performance:
-24.42%
1Y Performance:
-10.83%
1-Day Range:
$60.77
$63.21
1-Week Range:
$60.77
$64.11
52-Week Range:
$60.77
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
61.00 | 3.09B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Prestige Consumer Healthcare stock hits 52-week low at 61.27 USD - Investing.com
Pattern recognition hints at Prestige Consumer Healthcare Inc. upsideWeekly Stock Report & Fast Moving Stock Watchlists - newser.com
Prestige Consumer Healthcare Inc. stock outlook for YEARQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Building trade automation scripts for Prestige Consumer Healthcare Inc.Layoff News & Verified Momentum Stock Alerts - newser.com
Prestige Consumer Healthcare (NYSE:PBH) Receives Hold (C) Rating from Weiss Ratings - MarketBeat
DAVENPORT & Co LLC Purchases 5,264 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Will Prestige Consumer Healthcare Inc. (PBV) stock extend growth storyMarket Movers & Fast Entry High Yield Tips - newser.com
Volatility clustering patterns for Prestige Consumer Healthcare Inc.2025 Major Catalysts & Daily Stock Trend Reports - newser.com
Why Prestige Consumer Healthcare Inc. stock is popular among millennialsMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
Statistical indicators supporting Prestige Consumer Healthcare Inc.’s strengthMarket Sentiment Review & Verified Momentum Watchlists - newser.com
Sentiment analysis tools applied to Prestige Consumer Healthcare Inc.Recession Risk & Technical Pattern Recognition Alerts - newser.com
How Prestige Consumer Healthcare Inc. (PBV) stock performs during market turbulence2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Why analysts raise outlook for Prestige Consumer Healthcare Inc. stockDip Buying & Long-Term Safe Investment Ideas - newser.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $94.80 Consensus Target Price from Analysts - Defense World
Prestige Consumer Healthcare Inc. to Release Fiscal 2026 Second Quarter Earnings on November 6, 2025 - Quiver Quantitative
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results - The Manila Times
Q2 Results Nov 6: Prestige Consumer Healthcare to Host Webcast and Conference Call - Stock Titan
Real time social sentiment graph for Prestige Consumer Healthcare Inc.Weekly Trade Recap & Fast Entry High Yield Tips - newser.com
Chart based exit strategy for Prestige Consumer Healthcare Inc.Trade Entry Summary & Safe Investment Capital Preservation Plans - newser.com
Is Prestige Consumer Healthcare Inc. stock resilient in recession scenariosJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - newser.com
How Prestige Consumer Healthcare Inc. stock trades under stagflation2025 Pullback Review & Risk Managed Trade Strategies - newser.com
Full technical analysis of Prestige Consumer Healthcare Inc. stock2025 Valuation Update & Community Supported Trade Ideas - newser.com
Will Prestige Consumer Healthcare Inc. stock maintain strong growthQuarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Prestige Consumer Healthcare Stock Hits New 52-Week Low at $61.29 - Markets Mojo
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance
What margin trends mean for Prestige Consumer Healthcare Inc. stockJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Is Prestige Consumer Healthcare Inc. stock a contrarian opportunityDividend Hike & Accurate Entry/Exit Alerts - newser.com
What analysts say about Prestige Consumer Healthcare Inc stockFibonacci Extensions & Low Entry Capital Stocks - earlytimes.in
How Prestige Consumer Healthcare Inc. (PBV) stock trades under stagflationPortfolio Update Summary & Smart Investment Allocation Insights - newser.com
Prestige Consumer Healthcare stock hits 52-week low at 61.9 USD - Investing.com Nigeria
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):